Distinct oncogenic Ras signals characterized by profound differences in flux through the RasGDP/RasGTP cycle

References

• Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012; 481:157-63; PMID:22237106; http://dx.doi.org/10.1038/nature10725
   PubMed Web of Science ®Google Scholar
• Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med 2004; 350:1535-48; PMID:15071128; http://dx.doi.org/10.1056/NEJMra023001
   PubMed Web of Science ®Google Scholar
• Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354:166-78; PMID:16407512; http://dx.doi.org/10.1056/NEJMra052603
   PubMed Web of Science ®Google Scholar
• Thiel E, Kranz BR, Raghavachar A, Bartram CR, Löffler H, Messerer D, Ganser A, Ludwig WD, Büchner T, Hoelzer D. Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood 1989; 73:1247-58; PMID:2467704
   PubMed Web of Science ®Google Scholar
• Pullen J, Shuster JJ, Link M, Borowitz M, Amylon M, Carroll AJ, Land V, Look AT, McIntyre B, Camitta B. Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. Leukemia 1999; 13:1696-707; PMID:10557041; http://dx.doi.org/10.1038/sj.leu.2401555
   PubMed Web of Science ®Google Scholar
• Pui CH, Hancock ML, Head DR, Rivera GK, Look AT, Sandlund JT, Behm FG. Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia. Blood 1993; 82:889-94; PMID:7687897
   PubMed Web of Science ®Google Scholar
• Graux C, Cools J, Michaux L, Vandenberghe P, Hagemeijer A. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast. Leukemia 2006; 20:1496-510; PMID:16826225; http://dx.doi.org/10.1038/sj.leu.2404302
   PubMed Web of Science ®Google Scholar
• Grabher C, von Boehmer H, Look AT. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 2006; 6:347-59; PMID:16612405; http://dx.doi.org/10.1038/nrc1880
   PubMed Web of Science ®Google Scholar
• Lin YW, Nichols RA, Letterio JJ, Aplan PD. Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma. Blood 2006; 107:2540-3; PMID:16282337; http://dx.doi.org/10.1182/blood-2005-07-3013
   PubMed Web of Science ®Google Scholar
• Weng AP, Ferrando AA, Lee W, Morris JP 4th, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306:269-71; PMID:15472075; http://dx.doi.org/10.1126/science.1102160
   PubMed Web of Science ®Google Scholar
• von Lintig FC, Huvar I, Law P, Diccianni MB, Yu AL, Boss GR. Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia. Clin Cancer Res 2000; 6:1804-10; PMID:10815901
   PubMed Web of Science ®Google Scholar
• Mitin N, Rossman KL, Der CJ. Signaling interplay in Ras superfamily function. Curr Biol 2005; 15:R563-574; PMID:16051167; http://dx.doi.org/10.1016/j.cub.2005.07.010
   PubMed Web of Science ®Google Scholar
• Mor A, Philips MR. Compartmentalized Ras/MAPK signaling. Annu Rev Immunol 2006; 24:771-800; PMID:16551266; http://dx.doi.org/10.1146/annurev.immunol.24.021605.090723
   PubMed Web of Science ®Google Scholar
• Vetter IR, Wittinghofer A. The guanine nucleotide-binding switch in three dimensions. Science 2001; 294:1299-304; PMID:11701921; http://dx.doi.org/10.1126/science.1062023
   PubMed Web of Science ®Google Scholar
• Bos JL, Rehmann H, Wittinghofer A. GEFs and GAPs: critical elements in the control of small G proteins. Cell 2007; 129:865-77; PMID:17540168; http://dx.doi.org/10.1016/j.cell.2007.05.018
   PubMed Web of Science ®Google Scholar
• Downward J. Cancer biology: signatures guide drug choice. Nature 2006; 439:274-5; PMID:16421553; http://dx.doi.org/10.1038/439274a
   PubMed Web of Science ®Google Scholar
• Schubbert S, Bollag G, Shannon K. Deregulated Ras signaling in developmental disorders: new tricks for an old dog. Curr Opin Genet Dev 2007; 17:15-22; PMID:17208427; http://dx.doi.org/10.1016/j.gde.2006.12.004
   PubMed Web of Science ®Google Scholar
• Stone JC. Regulation and Function of the RasGRP family of ras activators in blood cells. Genes Cancer 2011; 2:320-34; PMID:21779502; http://dx.doi.org/10.1177/1947601911408082
   PubMedGoogle Scholar
• Jun JE, Rubio I, Roose JP. Regulation of Ras exchange factors and cellular localization of ras activation by lipid messengers in T Cells. Frontiers Immunol 2013; 4:239; http://dx.doi.org/10.3389/fimmu.2013.00239
   PubMed Web of Science ®Google Scholar
• Ksionda O, Limnander A, Roose JP. RasGRP Ras guanine nucleotide exchange factors in cancer. Front Biol (Beijing) 2013; 8:508-32; PMID:24744772; http://dx.doi.org/10.1007/s11515-013-1276-9
   PubMedGoogle Scholar
• Dower NA, Stang SL, Bottorff DA, Ebinu JO, Dickie P, Ostergaard HL, Stone JC. RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nat Immunol 2000; 1:317-21; PMID:11017103; http://dx.doi.org/10.1038/80799
   PubMed Web of Science ®Google Scholar
• Coughlin JJ, Stang SL, Dower NA, Stone JC. RasGRP1 and RasGRP3 regulate B cell proliferation by facilitating B cell receptor-Ras signaling. J Immunol 2005; 175:7179-84; PMID:16301621; http://dx.doi.org/10.4049/jimmunol.175.11.7179
   PubMed Web of Science ®Google Scholar
• King PD, Lubeck BA, Lapinski PE. Nonredundant functions for Ras GTPase-activating proteins in tissue homeostasis. Sci Signal 2013; 6:re1; PMID:23443682; http://dx.doi.org/10.1126/scisignal.2003669
   PubMed Web of Science ®Google Scholar
• Ward AF, Braun BS, Shannon KM. Targeting oncogenic Ras signaling in hematologic malignancies. Blood 2012; 120:3397-406; PMID:22898602; http://dx.doi.org/10.1182/blood-2012-05-378596
   PubMed Web of Science ®Google Scholar
• Ahuja HG, Foti A, Bar-Eli M, Cline MJ. The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Blood 1990; 75:1684-90; PMID:2183888
   PubMed Web of Science ®Google Scholar
• Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1:133-43; PMID:12086872; http://dx.doi.org/10.1016/S1535-6108(02)00032-6
   PubMed Web of Science ®Google Scholar
• Wiemels JL, Zhang Y, Chang J, Zheng S, Metayer C, Zhang L, Smith MT, Ma X, Selvin S, Buffler PA, et al. RAS mutation is associated with hyperdiploidy and parental characteristics in pediatric acute lymphoblastic leukemia. Leukemia 2005; 19:415-9; PMID:15674422; http://dx.doi.org/10.1038/sj.leu.2403641
   PubMed Web of Science ®Google Scholar
• Fruman DA, Rommel C. PI3K and cancer: lessons, challenges and opportunities. Nat Rev 2014; 13:140-56.
   Google Scholar
• Zenatti PP, Ribeiro D, Li W, Zuurbier L, Silva MC, Paganin M, Tritapoe J, Hixon JA, Silveira AB, Cardoso BA, et al. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia. Nat Genet 2011; 43:932-9; PMID:21892159; http://dx.doi.org/10.1038/ng.924
   PubMed Web of Science ®Google Scholar
• Kim R, Trubetskoy A, Suzuki T, Jenkins NA, Copeland NG, Lenz J. Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas. J Virol 2003; 77:2056-62; PMID:12525640; http://dx.doi.org/10.1128/JVI.77.3.2056-2062.2003
   PubMed Web of Science ®Google Scholar
• Klinger MB, Guilbault B, Goulding RE, Kay RJ. Deregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptors. Oncogene 2004; 24:2695-704; http://dx.doi.org/10.1038/sj.onc.1208334
   Web of Science ®Google Scholar
• Oki T, Kitaura J, Watanabe-Okochi N, Nishimura K, Maehara A, Uchida T, Komeno Y, Nakahara F, Harada Y, Sonoki T, et al. Aberrant expression of RasGRP1 cooperates with gain-of-function NOTCH1 mutations in T-cell leukemogenesis. Leukemia 2011; 26(5):1038-45.
   PubMed Web of Science ®Google Scholar
• Hartzell C, Ksionda O, Lemmens E, Coakley K, Yang M, Dail M, Harvey RC, Govern C, Bakker J, Lenstra TL, et al. Dysregulated RasGRP1 Responds to Cytokine Receptor Input in T Cell Leukemogenesis. Sci Signal 2013; 6:ra21; PMID:23532335; http://dx.doi.org/10.1126/scisignal.2003848
   PubMed Web of Science ®Google Scholar
• Lubeck BA, Lapinski PE, Oliver JA, Ksionda O, Parada LF, Zhu Y, Maillard I, Chiang M, Roose J, King PD. Cutting Edge: Codeletion of the Ras GTPase-Activating Proteins (RasGAPs) Neurofibromin 1 and p120 RasGAP in T Cells Results in the Development of T Cell Acute Lymphoblastic Leukemia. J Immunol 2015; 195:31-5; PMID:26002977; http://dx.doi.org/10.4049/jimmunol.1402639
   PubMed Web of Science ®Google Scholar
• Balgobind BV, Van Vlierberghe P, van den Ouweland AM, Beverloo HB, Terlouw-Kromosoeto JN, van Wering ER, Reinhardt D, Horstmann M, Kaspers GJ, Pieters R, et al. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. Blood 2008; 111:4322-8; PMID:18172006; http://dx.doi.org/10.1182/blood-2007-06-095075
   PubMed Web of Science ®Google Scholar
• Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012; 481:157-63; PMID:22237106; http://dx.doi.org/10.1038/nature10725
   PubMed Web of Science ®Google Scholar
• Neumann M, Heesch S, Schlee C, Schwartz S, Gökbuget N, Hoelzer D, Konstandin NP, Ksienzyk B, Vosberg S, Graf A, et al. Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations. Blood 2013; 121:4749-52; PMID:23603912; http://dx.doi.org/10.1182/blood-2012-11-465138
   PubMed Web of Science ®Google Scholar
• Ksionda O, Melton AA, Bache J, Tenhagen M, Bakker J, Harvey R, Winter SS, Rubio I, Roose JP. RasGRP1 overexpression in T-ALL increases basal nucleotide exchange on Ras rendering the Ras/PI3K/Akt pathway responsive to protumorigenic cytokines. Oncogene 2015; PMID:26549032
   PubMed Web of Science ®Google Scholar
• Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA, et al. Mutational landscape and significance across 12 major cancer types. Nature 2013; 502:333-9; PMID:24132290; http://dx.doi.org/10.1038/nature12634
   PubMed Web of Science ®Google Scholar
• Juntilla MM, Koretzky GA. Critical roles of the PI3K/Akt signaling pathway in T cell development. Immunol Lett 2008; 116:104-10; PMID:18243340; http://dx.doi.org/10.1016/j.imlet.2007.12.008
   PubMed Web of Science ®Google Scholar
• Gutierrez A, Sanda T, Grebliunaite R, Carracedo A, Salmena L, Ahn Y, Dahlberg S, Neuberg D, Moreau LA, Winter SS, et al. High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood 2009; 114:647-50; PMID:19458356; http://dx.doi.org/10.1182/blood-2009-02-206722
   PubMed Web of Science ®Google Scholar
• Maser RS, Choudhury B, Campbell PJ, Feng B, Wong KK, Protopopov A, O'Neil J, Gutierrez A, Ivanova E, Perna I, et al. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 2007; 447:966-71; PMID:17515920; http://dx.doi.org/10.1038/nature05886
   PubMed Web of Science ®Google Scholar
• Palomero T. et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007; 13:1203-10; PMID:17873882; http://dx.doi.org/10.1038/nm1636
   PubMed Web of Science ®Google Scholar
• Lonetti A, Antunes IL, Chiarini F, Orsini E, Buontempo F, Ricci F, Tazzari PL, Pagliaro P, Melchionda F, Pession A, et al. Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia. Leukemia 2013; 28(6):1196-206.
   PubMed Web of Science ®Google Scholar
• Piovan E, Yu J, Tosello V, Herranz D, Ambesi-Impiombato A, Da Silva AC, Sanchez-Martin M, Perez-Garcia A, Rigo I, Castillo M, et al. Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia. Cancer Cell 2013; 24:766-76; PMID:24291004; http://dx.doi.org/10.1016/j.ccr.2013.10.022
   PubMed Web of Science ®Google Scholar
• Hartzell C, Ksionda O, Lemmens E, Coakley K, Yang M, Dail M, Harvey RC, Govern C, Bakker J, Lenstra TL, et al. Dysregulated RasGRP1 Responds to Cytokine Receptor Input in T Cell Leukemogenesis. Sci Signal 2013; 6:ra21; PMID:23532335; http://dx.doi.org/10.1126/scisignal.2003848
   PubMed Web of Science ®Google Scholar
• Ikezoe T, Nishioka C, Bandobashi K, Yang Y, Kuwayama Y, Adachi Y, Takeuchi T, Koeffler HP, Taguchi H. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Leuk Res 2007; 31:673-82; http://dx.doi.org/10.1016/j.leukres.2006.08.001
   PubMed Web of Science ®Google Scholar
• Silva A, Yunes JA, Cardoso BA, Martins LR, Jotta PY, Abecasis M, Nowill AE, Leslie NR, Cardoso AA, Barata JT. PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability. J Clin Invest 2008; 118:3762-74; PMID:18830414; http://dx.doi.org/10.1172/JCI34616
   PubMed Web of Science ®Google Scholar
• Knight ZA, Lin H, Shokat KM. Targeting the cancer kinome through polypharmacology. Nat Rev Cancer 2010; 10:130-37; PMID:20094047; http://dx.doi.org/10.1038/nrc2787
   PubMed Web of Science ®Google Scholar
• Barata JT, Silva A, Brandao JG, Nadler LM, Cardoso AA, Boussiotis VA. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. J Exp Med 2004; 200:659-69; PMID:15353558; http://dx.doi.org/10.1084/jem.20040789
   PubMed Web of Science ®Google Scholar
• Coyle SM, Lim WA. Mapping the functional versatility and fragility of Ras GTPase signaling circuits through in vitro network reconstitution. Elife 2016; 5:e12435; PMID:26765565; http://dx.doi.org/10.7554/eLife.12435
   PubMedGoogle Scholar
• Ostrem JM, Peters U, Sos ML, Wells JA, Shokat KM. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature 2013; 503:548-51; PMID:24256730; http://dx.doi.org/10.1038/nature12796
   PubMed Web of Science ®Google Scholar
• Patricelli MP, Janes MR, Li LS, Hansen R, Peters U, Kessler LV, Chen Y, Kucharski JM, Feng J, Ely T, et al. Selective inhibition of oncogenic KRAS output with small molecules targeting the inactive state. Cancer Discov 2016; 6:316-29; PMID:26739882; http://dx.doi.org/10.1158/2159-8290.CD-15-1105
   PubMed Web of Science ®Google Scholar
• Lito P, Solomon M, Li LS, Hansen R, Rosen N. Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism. Science 2016; 351:604-8; PMID:26841430; http://dx.doi.org/10.1126/science.aad6204
   PubMed Web of Science ®Google Scholar